Cloacogenic Carcinoma — Clinical Trials

MONDO:00041293 activeLast updated: Mar 18, 2026, 5:34 AM

Trial Landscape

Cloacogenic Carcinoma has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment2

Procedure2

Biological Therapy2

2 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 2

Phase 3

Sponsor Types

NIH2Collaborative Network1

Trial Locations

United States3 trials

Canada1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 3Active, Not Recruiting

NCT03233711

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Jul 2018Est. completion: Dec 2027Updated: Mar 2026

Phase 3Active, Not Recruiting

NCT04444921

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Nov 2020Est. completion: Mar 2027Updated: Mar 2026

Phase 2Active, Not Recruiting

NCT04166318

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Sponsor:ECOG-ACRIN Cancer Research Group

United StatesStarted: Jan 2020Est. completion: Dec 2029Updated: Mar 2026

Stay informed about clinical trials for Cloacogenic Carcinoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 18, 2026 at 5:34 AM